Skip to main content
Earnings Labs
Inhibikase Therapeutics, Inc. logo

Inhibikase Therapeutics, Inc. (IKT) Earnings

NASDAQ·Healthcare·Biotechnology

$1.68

+0.60%

Mkt Cap $137.04M

EPS — Estimate vs Actual

Mkt Cap

$137.04M

P/E

Fwd P/E

P/S

Rev TTM

EPS TTM

-$0.51